79.7 F
New York
HomeMedicine

Medicine

Global Continuous Renal Replacement Therapy (CVVH, CVVHDF, CVVHD, SCUF) Industry Research 2024-2033

DUBLIN, March 29, 2024 /PRNewswire/ -- The "Global Continuous Renal Replacement Therapy Market: Focus on Modality, Product, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering. The global continuous renal replacement therapy (CRRT) market is witnessing significant growth, driven...

Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape

DUBLIN, March 29, 2024 /PRNewswire/ -- The "Global Acute Lymphoblastic Leukemia Therapeutics Market: Focus on Cell Type, Therapy Type, and Over 10 Countries' Data - Analysis and Forecast, 2024-2033" report has been added to  ResearchAndMarkets.com's offering. The global market for Acute Lymphoblastic Leukemia (ALL) is witnessing...

FDA Roundup: March 29, 2024

SILVER SPRING, Md., March 29, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA made several updates to the Mammography Quality Standards Act and Program section on the FDA...

Tampa General Hospital Recognized as One of America’s Greatest Workplaces for Women by Newsweek

The academic health system's inclusion on the list highlights an ongoing commitment to creating an equitable workplace.  TAMPA, Fla., March 29, 2024 /PRNewswire/ -- Tampa General Hospital (TGH) — the primary teaching hospital for the USF Health Morsani College of Medicine — is included in Newsweek's 2024 list of "America's Greatest...

First-in-Disease Use of Kyverna Therapeutics’ KYV-101 in Patients With Progressive Multiple Sclerosis Published in Med

Two patients were treated with KYV-101, a fully human anti-CD19 CAR T-cell product candidate, in Germany as part of a named patient program after failure to respond to conventional therapies The treatment resulted in an acceptable safety profile, with no observed clinical signs of early...

Sensorum Health partners with Intermountain Health to improve health outcomes and primary care access for older adults living independently with multiple chronic conditions

Partnership to prevent avoidable hospitalizations through early detection and primary care-led interventions with Sensorum Health's innovative platform. NEW YORK, March 29, 2024 /PRNewswire/ -- Sensorum Health, an innovative health technology and services company that provides advanced remote monitoring technology and integrated clinical staff, has entered...